Quantitative Analyses of Schizophrenia-Associated Metabolites in Serum: Serum D-Lactate Levels Are Negatively Correlated with Gamma-Glutamylcysteine in Medicated Schizophrenia Patients

Fast and simultaneous analysis of biothiols by high-performance liquid chromatography with fluorescence detection under hydrophilic interaction chromatography conditions

(2013) Muneki Isokawa et al.   ANALYST

Sex differences in lipid peroxidation and fatty acid levels in recent onset schizophrenia

(2013) Julieta Ramos-Loyo et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Kynurenines: from the perspective of major psychiatric disorders

(2012) Aye M. Myint   FEBS Journal

Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitrostudy)

(2012) Čedo Miljević et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Metabolomic Analysis of Biochemical Changes in the Plasma and Urine of First-Episode Neuroleptic-Naïve Schizophrenia Patients after Treatment with Risperidone

(2012) Hua-Lin Cai et al.   JOURNAL OF PROTEOME RESEARCH

Plasma levels of D-serine in Brazilian individuals with schizophrenia

(2012) Marilia A. Calcia et al.   SCHIZOPHRENIA RESEARCH

Suppression of Oxidative Stress by  -Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor

(2012) T. Shimazu et al.   SCIENCE

Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia

(2011) Motoko Maekawa et al.   CURRENT PHARMACEUTICAL DESIGN

Enantioselective determination of 3-hydroxybutyrate in the tissues of normal and streptozotocin-induced diabetic rats of different ages

(2011) Wei-Yu Hsu et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Metabolomic Profiling to Identify Potential Serum Biomarkers for Schizophrenia and Risperidone Action

(2011) Jiekun Xuan et al.   JOURNAL OF PROTEOME RESEARCH

Potential metabolite markers of schizophrenia

(2011) J Yang et al.   MOLECULAR PSYCHIATRY

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

(2010) Jeffrey K. Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia

(2010) Makoto Arai et al.   ARCHIVES OF GENERAL PSYCHIATRY

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Oxidative stress in schizophrenia: An integrated approach

(2010) Byron K.Y. Bitanihirwe et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia

(2009) J K Yao et al.   MOLECULAR PSYCHIATRY

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

(2009) Monia Raffa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Functional significance of the GAG trinucleotide-repeat polymorphism in the gene for the catalytic subunit of γ-glutamylcysteine ligase

(2008) Sailendra N. Nichenametla et al.   FREE RADICAL BIOLOGY AND MEDICINE

Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

(2008) Caroline Madeira et al.   SCHIZOPHRENIA RESEARCH